Search for the latest oncology news by tumour type
A novel antibody-drug conjugate (ADC), iza-bren (BL-B01D1), demonstrated encouraging safety and efficacy results in previously…
A combination of iza-bren (BL-B01D1), a novel bispecific antibody-drug conjugate (ADC), with osimertinib demonstrated a…
Prostate cancer is one of the leading causes of cancer-related death in men. Most patients…
Many modern cancer treatments are highly effective at reducing or eliminating tumours, but they can…
People with type 2 obesity-driven diabetes tend to have more aggressive breast cancers, but no…
The mitochondria may be the powerhouse of the cell, but mounting evidence suggests this organelle…
A natural compound could help fight aggressive leukaemia and amplify the effect of chemotherapy drugs.…
In a preclinical study, researchers found that tamoxifen encourages uterine cell growth; the findings could…
Join Medical Oncologist and International Cancer Survivorship Expert, Professor Bogda Koczwara AM for Series 2 of Supportive Care Matter. “If it were a pill, we would all want it.” This powerful opening statement captures the essence of ground-breaking research that’s transforming our understanding of cancer survivorship care: exercise. In this episode, Bogda chats to Professor Haryana Dhillon and Professor Janette Vardy about the CHALLENGE study.
Men assessed as healthy after a pathologist analyzes their tissue sample may still have an…